Drugs / GCFLU Pre-filled Syringe inj.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT02121782 Comparator | May → Jun 2014 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Phase 3 | NCT03285997 Comparator | Sep 2017 → May 2018 | — | Green Cross Corporation | Unknown | Met primary |
| Phase 3 | NCT02541253 Comparator | Sep 2015 → Jun 2016 | influenza | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCFLU Pre-filled Syringe inj. | “GC Flu Pre-filled Syringe Inj. (a marketed TIV)” NCT02121782 ↗ |
| Modality | Vaccine | “The comparator, GC Flu pre-filled syringe inj. is a trivalent influenza vaccine (TIV)” NCT02121782 ↗ |
| Route | Intramuscular | “GC Flu Pre-filled Syringe Inj., 0.5ml, intramuscular, a single dosing at Day 1” NCT02121782 ↗ |